#targets
Latest news and interesting information about targets.
Encompass Health SWOT analysis: navigating Medicare changes
Encompass Health SWOT analysis: Medicare changes, strong financials, and market share growth.
Aghdam construction targets revealed
Emin Huseynov reveals Aghdam construction targets: residential complexes 4 and 5, two villages, and Fuzuli projects. 25 billion manats allocated.
New Drug Operation Targets Celebrities in Turkey: 25 Detained Including Fatih Karaca, Serenay Sarıkaya
Turkey launches new drug operation targeting celebrities: 25 detained including singer Fatih Karaca and actresses Serenay Sarıkaya and Feyza Civelek.
Nvidia bets on new chip to fuel growth
Nvidia bets on new Vera chip to sustain growth, Q2 revenue forecast beats estimates.
Carrier Global SWOT: Transformation & Growth
Carrier Global SWOT analysis: company transformation, growth prospects and risks. Focus on electrification, data centers and aftermarket services.
ConocoPhillips SWOT Analysis
ConocoPhillips SWOT analysis: free cash flow, capital returns, and oil price debates.
Varonis SWOT: Churn Headwinds in SaaS Shift
Varonis Systems SWOT analysis: customer churn and market challenges amid SaaS shift. ARR growth and competitive analysis.
State Street SWOT: mixed outlook amid rising costs
State Street SWOT analysis: mixed outlook due to rising expenses and FX exposure, balanced by mandate backlog and margin expansion.
Insight Partners sells $447,306 in Coursera stock
Insight Partners sold 78,628 Coursera shares for $447,306. Stock at $5.25 near 52-week low. Bond.az analysis.
Strategy CFO sells $927,865 in shares
Strategy CFO Andrew Kang sold $927,865 worth of shares. The sale was related to RSU vesting and tax obligations.
Klaviyo CEO sells $2.98M in shares
Klaviyo co-CEO Andrew Bialecki sold 200,000 shares for $2.98M. Stock down 54% in past year. Bond.az analysis suggests undervaluation.
Sysco stock: food distributor grows on case growth
Sysco stock: food distributor grows on case growth. Fiscal 2026 results beat estimates. Bond.az analysis.
Liquidia CEO Roger Jeffs sells $4.4m in LQDA stock
Liquidia CEO Roger Jeffs sells $4.42 million in LQDA stock over three days in May. The sales were disclosed in a Form 4 filing.
Bob R Simpson TXO Partners director buys $1.97m
TXO Partners director Bob R Simpson buys $1.97 million in common units. Shares up 31% YTD; analysts maintain $19-$22 target.
Stifel Initiates Eupraxia with Buy Rating
Stifel initiated coverage on Eupraxia Pharmaceuticals with a Buy rating and $25 target. Diffusphere platform and strong finances highlighted.
Enliven CMO sells $198,971 in stock
Enliven Therapeutics CMO Helen Collins sold $198,971 in stock. New data on ELVN-001 for CML released.
Biotech at Inflection Point: JPMorgan Covers 14 Firms | Bond.az
JPMorgan covers 14 biotech firms at inflection point, with ratings and price targets. See which companies are poised for growth and the catalysts ahead.
Marvell Technology stock hits all-time high at 192.21 USD
Marvell Technology stock hits all-time high at 192.21 USD, with 217% yearly gain and $167B market cap. Analyst targets raised.
Turkey's new long-range missile enters service
Turkey's new Tayfun Block-2 long-range missile has entered service with the Turkish army. Developed with domestic technology, it can strike strategic targets.
Seagate SWOT: Tight supply and tech shift
Seagate Technology SWOT analysis explores tight supply, HAMR technology transition, and market position. Read on Bond.az.
William Blair Starts Insulet at Outperform
William Blair initiates Insulet at Outperform. Stock trades at 24x EPS, undervalued per Bond.az. Key concerns and catalysts detailed.
Deutsche Bank upgrades Centene stock on earnings recovery
Deutsche Bank upgrades Centene stock to Buy with a new price target of $80. Bond.az analysis highlights undervaluation. Latest news on Centene.
Deutsche Bank upgrades Elevance stock
Deutsche Bank upgraded Elevance Health to Buy with a $498 price target, citing stable managed care market. Strong Q1 results also boost confidence.
Alpha Tau Stock Gets Buy Rating, $15 Target
H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.
H.C. Wainwright Reiterates Protara Buy Rating
H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.
Elia Reaffirms 2026 Guidance, Shares Rise
Elia reaffirmed its 2026 guidance with net profit forecast of €690-740 million. Shares rose 1.1% in Belgium.
Citizens Raises Relay Price Target to $21
Citizens raises Relay Therapeutics price target to $21 on strong trial data for zovegalisib, with shares up 296%.
Indonesia central bank hikes rates to support rupiah
Indonesia's central bank raised interest rates by 50 bps to support the rupiah. Learn about the policy move, market reaction, and economic outlook.
AMD SWOT: AI boom faces capacity constraints
AMD SWOT analysis: AI boom meets capacity constraints and competition. Make informed investment decisions with Bond.az.
Jefferies Initiates SAB Biotherapeutics with Buy
Jefferies initiates coverage on SAB Biotherapeutics with a Buy rating and $11 target, focusing on SAB-142 diabetes therapy.
...